Keya Watkins, Senior Vice President, Catalyst Oncology

Professional Overview

Keya Watkins is a seasoned pharmaceutical and clinical research executive with over 25 years of experience leading complex drug development programs and clinical operations initiatives. As the Senior Vice President of Catalyst Oncology at Catalyst Clinical Research, she oversees the strategic direction and execution of oncology-focused clinical trials, leveraging her deep expertise in the field to drive innovative therapies towards regulatory approval.

Experience Summary

Current Role

In her current role as Senior Vice President of Catalyst Oncology, Keya is responsible for leading the oncology division and managing a team of clinical development professionals. She is instrumental in setting the strategic vision for the company's oncology portfolio, ensuring seamless operational execution, and fostering collaborative partnerships with key stakeholders in the industry. Under her guidance, Catalyst Oncology has achieved significant milestones, including the successful completion of several phase II and III oncology trials and the advancement of promising drug candidates through the regulatory approval process.

Career Progression

Keya's extensive career in the pharmaceutical and clinical research industry spans various leadership positions, including her previous roles as Senior Vice President of Clinical Development Operations at Catalyst Clinical Research, Vice President of Clinical Operations at Clinipace, and senior-level positions at WIRB-Copernicus Group, ePharmaSolutions, and Theorem (now Chiltern). Throughout her career, she has demonstrated a strong track record of driving operational excellence, optimizing clinical trial processes, and enhancing patient outcomes.

Academic Background

Keya holds a Bachelor of Science degree in Nutrition from Graduate Hospital, where she graduated with distinction. Her academic background, combined with her extensive industry experience, has equipped her with a unique blend of scientific expertise and practical business acumen.

Areas of Expertise

Keya's areas of expertise include clinical trial design, project management, and the oversight of complex drug development programs, with a particular focus on oncology therapeutics. She has a proven ability to lead cross-functional teams, foster collaborative partnerships, and implement innovative strategies to streamline clinical operations and accelerate the path to regulatory approval.

Professional Impact

Keya's contributions to the pharmaceutical and clinical research industry have been widely recognized. She has successfully managed the execution of numerous phase II and III oncology trials, leading to the approval of several cancer treatments that have positively impacted patient lives. Keya's industry thought leadership and commitment to advancing the field of oncology drug development have earned her a reputation as a highly respected and influential figure in the industry.

Conclusion

With her extensive experience, strong leadership skills, and deep scientific expertise, Keya Watkins is poised to continue driving Catalyst Oncology's success in the development of innovative cancer therapies. Her unwavering dedication to improving patient outcomes and her ability to navigate the complex landscape of clinical research make her a valuable asset to the organization and the broader pharmaceutical industry.